Welcome to Going Beyond. In this section, the evidence for systemic medications and surgery will be reviewed. Techniques for pelvic floor exercises and psychological therapy for interested family physicians will be outlined.
Systemic Medications
A variety of medications have been proposed for the treatment of vulvodynia. The quality of studies evaluating the effectiveness of these medications are varied and reported outcome measures are inconsistent. Currently, there is insufficient evidence to recommend the routine use of systemic medication for the management of vulvodynia. Referral to a vulvodynia-aware physician is recommended for decision-making. However, based on their own experience, many vulvar experts believe there is a role for the use of these medications in select circumstances (Sadownik, 2014). At the B.C. Centre for Vulvar Health (BCCVH), oral pain adjuvants are used as first-line therapy only in patients with moderate to severe vulvar pain that is spontaneous. Typically, medication is one of nortriptyline, desipramine, or gabapentin and is initiated at a low and titrate up over slowly over a month. At the BCCVH, oral pain adjuvants are not used in the treatment of provoked vulvodynia. Medication should be chosen based on patient’s medical history and the medication side effect profile. Patients may not notice improvement in pain until several weeks.